{"id":"https://openalex.org/W4392679776","doi":"https://doi.org/10.1158/0008-5472.c.6506874","title":"Data from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity","display_name":"Data from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4392679776","doi":"https://doi.org/10.1158/0008-5472.c.6506874"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6506874","doi":"https://doi.org/10.1158/0008-5472.c.6506874","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6506874","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6506874","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027381243","display_name":"Hillary G. Caruso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hillary G. Caruso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059790021","display_name":"Lenka V. Hurton","orcid":"https://orcid.org/0000-0001-5670-5155","observed_orcids":["https://orcid.org/0000-0001-5670-5155"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lenka V. Hurton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045801","display_name":"Amer M. Najjar","orcid":"https://orcid.org/0000-0002-6414-7234","observed_orcids":["https://orcid.org/0000-0002-6414-7234"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amer Najjar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037142754","display_name":"David Rushworth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Rushworth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110488577","display_name":"Sonny Ang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonny Ang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068165365","display_name":"Simon Olivares","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Olivares","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113724652","display_name":"Tiejuan Mi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tiejuan Mi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967032","display_name":"Kirsten C. Switzer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirsten Switzer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041460360","display_name":"Harjeet Singh","orcid":"https://orcid.org/0000-0002-0748-9473","observed_orcids":["https://orcid.org/0000-0002-0748-9473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harjeet Singh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077357181","display_name":"Helen M. Huls","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Huls","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019752519","display_name":"Dean Anthony Lee","orcid":"https://orcid.org/0000-0001-6693-5392","observed_orcids":["https://orcid.org/0000-0001-6693-5392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dean A. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079081497","display_name":"Amy B. Heimberger","orcid":"https://orcid.org/0000-0002-9970-8695","observed_orcids":["https://orcid.org/0000-0002-9970-8695"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy B. Heimberger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048913229","display_name":"Richard E. Champlin","orcid":"https://orcid.org/0000-0002-4314-5037","observed_orcids":["https://orcid.org/0000-0002-4314-5037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard E. Champlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5007081796","display_name":"Laurence J.N. Cooper","orcid":"https://orcid.org/0000-0003-1460-3905","observed_orcids":["https://orcid.org/0000-0003-1460-3905"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurence J.N. Cooper","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9539999961853027},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.5070000290870667},{"id":"https://openalex.org/keywords/nimotuzumab","display_name":"nimotuzumab","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.44999998807907104},{"id":"https://openalex.org/keywords/normal-tissue-toxicity","display_name":"normal tissue toxicity","score":0.6489999890327454},{"id":"https://openalex.org/keywords/t-cell-effector-function","display_name":"T cell effector function","score":0.6499999761581421},{"id":"https://openalex.org/keywords/tumor-cell-detection","display_name":"cancer cell detection","score":0.3490000069141388},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.6583316922187805},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.33094826340675354},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.16050955653190613},{"id":"https://openalex.org/C24326235","wikidata":"https://www.wikidata.org/wiki/Q126095","display_name":"Electronic engineering","level":1,"score":0.10047805309295654}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6506874","doi":"https://doi.org/10.1158/0008-5472.c.6506874","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6506874","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6506874","doi":"https://doi.org/10.1158/0008-5472.c.6506874","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6506874","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1916979945","https://openalex.org/W4392680435","https://openalex.org/W2110641339","https://openalex.org/W4392846933","https://openalex.org/W3133429828","https://openalex.org/W114980631","https://openalex.org/W3133661829","https://openalex.org/W3035759125","https://openalex.org/W2766362802","https://openalex.org/W3082774197"],"abstract_inverted_index":{"Abstract":[0],"Many":[1],"tumors":[2],"overexpress":[3],"tumor-associated":[4],"antigens":[5],"relative":[6],"to":[7,21,28,38,117,121,137],"normal":[8,34,48],"tissue,":[9],"such":[10],"as":[11,84],"EGFR.":[12,107],"This":[13],"limits":[14],"targeting":[15],"by":[16,58,103],"human":[17],"T":[18,41,69,95,135],"cells":[19,42,49,70,76,96,136],"modified":[20],"express":[22],"chimeric":[23],"antigen":[24],"receptors":[25],"(CAR)":[26],"due":[27],"potential":[29],"for":[30],"deleterious":[31],"recognition":[32],"of":[33,44,55,87,94,106,114,124],"cells.":[35,142],"We":[36],"sought":[37],"generate":[39],"CAR+":[40],"capable":[43],"distinguishing":[45],"malignant":[46,139],"from":[47,62,140],"based":[50],"on":[51],"the":[52,85,92,104,112,122],"disparate":[53],"density":[54,86,105],"EGFR":[56,88,125],"expression":[57,126],"generating":[59],"two":[60],"CARs":[61,115],"monoclonal":[63],"antibodies":[64],"that":[65],"differ":[66],"in":[67,127],"affinity.":[68],"with":[71,131],"low-affinity":[72],"nimotuzumab-CAR":[73],"selectively":[74],"targeted":[75],"overexpressing":[77],"EGFR,":[78],"but":[79],"exhibited":[80],"diminished":[81],"effector":[82],"function":[83],"decreased.":[89],"In":[90,108],"contrast,":[91],"activation":[93],"bearing":[97],"high-affinity":[98],"cetuximab-CAR":[99],"was":[100],"not":[101],"affected":[102],"summary,":[109],"we":[110],"describe":[111],"generation":[113],"able":[116],"tune":[118],"T-cell":[119],"activity":[120],"level":[123],"which":[128],"a":[129],"CAR":[130],"reduced":[132],"affinity":[133],"enabled":[134],"distinguish":[138],"nonmalignant":[141],"Cancer":[143],"Res;":[144],"75(17);":[145],"3505\u201318.":[146],"\u00a92015":[147],"AACR.":[148]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-03-13T00:00:00"}